PONZONI, MAURILIO
 Distribuzione geografica
Continente #
NA - Nord America 11.674
EU - Europa 11.313
AS - Asia 11.161
SA - Sud America 3.171
Continente sconosciuto - Info sul continente non disponibili 407
AF - Africa 246
OC - Oceania 26
Totale 37.998
Nazione #
US - Stati Uniti d'America 10.893
RU - Federazione Russa 6.063
SG - Singapore 3.854
CN - Cina 3.327
BR - Brasile 2.561
IT - Italia 1.924
HK - Hong Kong 1.525
SE - Svezia 1.183
VN - Vietnam 1.094
FR - Francia 560
DE - Germania 429
BD - Bangladesh 407
CA - Canada 348
GB - Regno Unito 309
AR - Argentina 240
IN - India 188
FI - Finlandia 182
MX - Messico 148
AT - Austria 125
EC - Ecuador 118
ID - Indonesia 108
IE - Irlanda 105
JP - Giappone 102
NL - Olanda 84
TR - Turchia 84
IQ - Iraq 74
ES - Italia 73
ZA - Sudafrica 71
CO - Colombia 69
PL - Polonia 68
PY - Paraguay 51
JM - Giamaica 49
MA - Marocco 47
VE - Venezuela 43
CL - Cile 42
PK - Pakistan 36
SA - Arabia Saudita 36
UA - Ucraina 36
CR - Costa Rica 34
MY - Malesia 33
GT - Guatemala 29
UZ - Uzbekistan 29
HN - Honduras 28
KE - Kenya 27
TN - Tunisia 25
EG - Egitto 24
TT - Trinidad e Tobago 24
AE - Emirati Arabi Uniti 23
KR - Corea 23
PE - Perù 23
SV - El Salvador 23
AU - Australia 22
PH - Filippine 21
NI - Nicaragua 20
IR - Iran 19
PT - Portogallo 19
LT - Lituania 16
BE - Belgio 15
DZ - Algeria 15
IL - Israele 15
JO - Giordania 15
PR - Porto Rico 15
BB - Barbados 14
RO - Romania 14
LB - Libano 13
MD - Moldavia 13
NP - Nepal 13
OM - Oman 13
UY - Uruguay 13
DO - Repubblica Dominicana 12
AL - Albania 11
KZ - Kazakistan 11
BO - Bolivia 10
CH - Svizzera 10
TW - Taiwan 10
AZ - Azerbaigian 9
KW - Kuwait 9
PS - Palestinian Territory 9
TH - Thailandia 9
CZ - Repubblica Ceca 8
CY - Cipro 7
DK - Danimarca 7
ET - Etiopia 7
GP - Guadalupe 7
BH - Bahrain 6
BY - Bielorussia 6
CI - Costa d'Avorio 6
HR - Croazia 6
HU - Ungheria 6
SY - Repubblica araba siriana 6
BA - Bosnia-Erzegovina 5
BG - Bulgaria 5
BS - Bahamas 5
CW - ???statistics.table.value.countryCode.CW??? 5
GG - Guernsey 5
LV - Lettonia 5
NO - Norvegia 5
PA - Panama 5
RS - Serbia 5
SC - Seychelles 5
Totale 37.508
Città #
Dallas 1.656
Singapore 1.578
Hong Kong 1.513
Ashburn 1.487
Moscow 1.324
San Jose 1.062
Council Bluffs 607
Shanghai 601
Milan 554
Hefei 512
Princeton 460
Lawrence 457
Lauterbourg 440
Ho Chi Minh City 423
Beijing 403
New York 373
Santa Clara 285
São Paulo 212
Hanoi 203
Los Angeles 202
Phoenix 148
Nuremberg 147
Rome 136
Helsinki 124
Dublin 101
Rio de Janeiro 98
Miano 94
Atlanta 84
Munich 79
Boardman 76
Chicago 73
Montreal 72
Orem 71
Toronto 71
Brooklyn 69
Tokyo 69
North Bergen 67
London 57
Belo Horizonte 56
Vienna 56
Chennai 53
Denver 52
Warsaw 51
Biên Hòa 50
Naples 49
Houston 48
The Dalles 48
Buffalo 47
Mexico City 46
Brasília 44
Guayaquil 43
Washington 43
Boston 40
Guangzhou 40
Poplar 39
Haiphong 38
Turku 38
Curitiba 37
Da Nang 37
Frankfurt am Main 37
Bologna 36
Johannesburg 36
Seattle 36
Quito 35
Stockholm 35
Omaha 34
Porto Alegre 34
Columbus 31
San Francisco 31
Tianjin 31
Mumbai 30
Salvador 29
Campinas 28
Dhaka 28
Las Vegas 28
Manchester 28
Miami 28
Kingston 27
Baghdad 26
Charlotte 26
Jakarta 25
Nairobi 25
Tashkent 25
Asunción 24
Shenzhen 24
Sorocaba 24
Florence 23
Hangzhou 23
San José 23
Brescia 22
Goiânia 22
Hải Dương 22
Philadelphia 22
Guatemala City 21
Osasco 21
Pune 21
Ankara 20
Cesano Boscone 20
San Salvador 20
Santiago 20
Totale 18.044
Nome #
Definition, diagnosis, and management of intravascular large B-Cell lymphoma: Proposals and perspectives from an international consensus meeting 415
Identification of CXCL13 as a new marker for follicular dendritic cell sarcoma 271
Clinical Relevance of the Dose of Cytarabine in the Upfront Treatment of Primary CNS Lymphomas with Methotrexate-Cytarabine Combination 224
3D-culture of CLL cells in bioreactor identifies the bone marrow as a key regulator of HS1 function in response to Ibrutinib 222
EA4HP24-LYWS-293 An indolent EBV-related clonal T-cell proliferation presenting as chronic rhinosinusitis 211
Regression of ocular adnexal lymphoma after Chlamydia psittaci-eradicating antibiotic therapy 197
[Clinical value of spleen autograft]. FT Considerazioni sul valore clinico dell'autoinnesto di milza 197
Infusion of suicide-gene-engineered donor lymphocytes after family haploidentical haemopoietic stem-cell transplantation for leukaemia (the TK007 trial): a non-randomised phase I-II study 185
A multicenter study of treatment of primary CNS lymphoma 176
Case Report: Consistent disease manifestations with a staggered time course in two identical twins affected by adenosine deaminase 2 deficiency 169
A retinoic acid-dependent stroma-leukemia crosstalk promotes chronic lymphocytic leukemia progression 165
3D co-culture model of chronic lymphocytic leukemia bone marrow microenvironment predicts patient-specific response to mobilizing agents 164
A dose-dense short-term therapy for human immunodeficiency virus/acquired immunodeficiency syndrome patients with high-risk Burkitt lymphoma or high-grade B-cell lymphoma: safety and efficacy results of the “CARMEN” phase II trial 162
ABS0671 IgG4-RELATED DISEASE IN OVERLAP WITH IDIOPATHIC MULTICENTRIC CASTLEMAN DISEASE: CLINICAL-PATHOLOGICAL CHARACTERISTICS AND THERAPEUTIC IMPLICATIONS OF AN ORPHAN DISEASE 162
BCL2, BCL6, MYC, MALT 1, and BCL10 rearrangements in nodal diffuse large B-cell lymphomas: a multicenter evaluation of a new set of fluorescent in situ hybridization probes and correlation with clinical outcome 160
CRISPR-based gene disruption and integration of high-avidity, WT1-specific T cell receptors improve antitumor T cell function 160
Bone marrow metastases: a systematic review of a neglected involvement in malignant melanoma 159
THREE-HOUR INFUSION OF METHOTREXATE AT 3 g/m2 SIGNIFICANTLY REDUCES CNS RELAPSES AND IMPROVES SURVIVAL IN PATIENTS WITH LARGE B-CELL LYMPHOMAS AND INCREASED CNS RISK 155
CLINICAL AND PATHOLOGICAL CHARACTERISTICS OF HIGH-GRADE B-CELL LYMPHOMAS TRANSFORMED FROM INDOLENT LYMPHOMAS IN HIV-NEGATIVE AND HIV-POSITIVE PATIENTS 153
Follicular helper T cell signature of replicative exhaustion, apoptosis and senescence in common variable immunodeficiency 146
A Mechanistic Role For Mir-126, a Hematopoietic Stem Cell Microrna, In Acute Leukemias 144
A refined cell-of-origin classifier with targeted NGS and artificial intelligence shows robust predictive value in DLBCL 142
A MULTICENTER TRIAL ASSESSING FEASIBILITY AND EFFICACY OF A COMBINATION OF HIGH-DOSE METHOTREXATE, CYTARABINE AND THIOTEPA IN PATIENTS WITH PRIMARY CNS LYMPHOMA: IMPACT ON OUTCOME OF CYTARABINE DOSE 140
A Novel t(5;7)(q31;q21)/CDK6::IL3 in Immature T-cell Acute Lymphoblastic Leukemia With IL3 Expression and Eosinophilia 139
A novel Rag2(-/-)gamma(-/-)(c)-xenograft model of human CLL 138
A PHASE II STUDY TO INVESTIGATE THE PREVALENCE OF INFECTIOUS AGENTS IN OCULAR ADNEXAE MARGINAL ZONE LYMPHOMA (OAMZL) AND THE EFFICACY OF ANTIBIOTIC THERAPY (IELSG#27 TRIAL) 138
Biomarker testing implementation for molecularly targeted therapy in non-small cell lung cancer patients 136
A bitter effect: thrombocytopenia induced by a quinidine-containing beverage 134
Immune Regulatory Neural Stem/Precursor Cells Protect from Central Nervous System Autoimmunity by Restraining Dendritic Cell Function 134
Liquid biopsy of cerebrospinal fluid enabling the detection and therapeutic targeting of the BRAFV600E mutation in a patient with overlapping Erdheim-Chester/Rosai-Dorfman disease 131
In vitro models of the crosstalk between multiple myeloma and stromal cells recapitulate the mild NF-κB activation observed in vivo 129
B lymphocytes directly contribute to tissue fibrosis in patients with IgG4-related disease. 129
Case report: Cytopenias in VEXAS syndrome - a WHO 2022 based approach in a single-center cohort 128
Central nervous system marginal zone B-cell lymphoma associated with chlamydophila psittaci infection 127
Improving the antitumor activity of R-CHOP with NGR-hTNF in primary CNS lymphoma: Final results of a phase 2 trial 127
A practical algorithmic approach to mature aggressive B cell lymphoma diagnosis in the double/triple hit era: selecting cases, matching clinical benefit: A position paper from the Italian Group of Haematopathology (G.I.E.) 127
SHORT-TERM DOSE-DENSE “CARMEN” THERAPY IS BETTER TOLERATED AND EVENLY EFFECTIVE THAN OTHER INTENSIFIED REGIMENS IN HIV- AND HIV+ PATIENTS WITH BURKITT LYMHOMA 126
A virtual tissue bank for primary central nervous system lymphomas in immunocompetent individuals 126
Editing T cell specificity towards leukemia by zinc finger nucleases and lentiviral gene transfer 126
CAR T cell manufacturing from naive/stem memory T lymphocytes enhances antitumor responses while curtailing cytokine release syndrome 124
Antitumor effects of HSV-TK-engineered donor lymphocytes after allogeneic stem-cell transplantation 122
A screening study of Chlamydia psittaci infection in 172 cases of nodal and extranodal non-hodgkin lymphomas 121
Inhibition of chronic lymphocytic leukemia progression by full-length chromogranin A and its N-terminal fragment in mouse models 121
Whole-brain radiotherapy or autologous stem-cell transplantation as consolidation strategies after high-dose methotrexate-based chemoimmunotherapy in patients with primary CNS lymphoma: results of the second randomisation of the International Extranodal Lymphoma Study Group-32 phase 2 trial 121
Case report: Successful use of mepolizumab for immune checkpoint inhibitors–induced hypereosinophilic syndrome in two patients with solid malignancies 120
Lack of TIR8/SIGIRR triggers progression of chronic lymphocytic leukemia in mouse models 120
Bone marrow as an alternative site for islet transplantation 120
Chemoimmunotherapy with methotrexate, cytarabine, thiotepa, and rituximab (MATRix regimen) in patients with primary CNS lymphoma: Results of the first randomisation of the International Extranodal Lymphoma Study Group-32 (IELSG32) phase 2 trial 120
Primary central nervous system lymphoma 120
A Six-Month Regimen of Oral Clarithromycin Is a Feasible and Active Therapy for Patients with Relapsed/Refractory Marginal Zone B-Cell Lymphoma of MALT-Type 119
CD4+ T cells license Kupffer cells to reverse CD8+ T cell dysfunction induced by hepatocellular priming 118
Ex vivo gene therapy with lentiviral vectors rescues adenosine deaminase (ADA)-deficient mice and corrects their immune and metabolic defects 118
ORBIT IRRADIATION AS SALVAGE TREATMENT FOR PATIENTS WITH OCULAR ADNEXAL MALT LYMPHOMA (OAML) RELAPSED AFTER OR REFRACTORY TO CHLAMYDIA PSITTACI-ERADICATING ANTIBIOTIC THERAPY 117
Targeting the LYN/HS1 signaling axis in chronic lymphocytic leukemia 115
In vitro and in vivo model of a novel immunotherapy approach for chronic lymphocytic leukemia by anti-CD23 chimeric antigen receptor 115
Perivascular expression of CXCL9 and CXCL12 in primary central nervous system lymphoma: T-cell infiltration and positioning of malignant B cells 115
Salvage Irradiation for Ocular Adnexal Mucosa Associated Lymphoid Tissue Lymphoma Refractory to Chlamydia psittaci Eradication 115
A PHASE II TRIAL TO INVESTIGATE THE LINK WITH INFECTIOUS AGENTS IN OCULAR ADNEXAL MARGINAL ZONE LYMPHOMA, ESPECIALLY WITH CHLAMYDIA SPECIES, AND THE ANTINEOPLASTIC EFFECTS OF DOXYCYCLINE (IELSG#27) 114
DNA methylation alterations in prostate cancer: from diagnosis to treatment 113
Chronic lymphocytic leukemia: the pathologist's view of lymph node microenvironment 113
A woman and her canary: a tale of chlamydiae and lymphomas 112
Clinical activity of rituximab in extranodal marginal zone B-cell lymphoma of MALT type 111
Anti-CD20 monoclonal antibody (Rituximab) in gastric extranodal marginal zone (MALT) non-Hodgkin's lymphoma (NHL) patients: Clinical and biological results (Phase II study). 111
Aggressive B-cell lymphoma with MYC/TP53 dual alterations displays distinct clinicopathobiological features and response to novel targeted agents 110
A reappraisal of the diagnostic and therapeutic management of uncommon histologies of primary ocular adnexal lymphoma 110
Graft-versus leukemia effect of HLA-haploidentical central-memory T cells expanded with leukemic APCs and modified with a suicide gene 110
CD4+T cells sustain aggressive chronic lymphocytic leukemia in Em- TCL1 mice through a CD40L-independent mechanism 109
Autologous Pancreatic Islet Transplantation in Human Bone Marrow 108
Over 30% of patients with splenic marginal zone lymphoma express the same immunoglobulin heavy variable gene: ontogenetic implications 108
EZN-2208 treatment suppresses chronic lymphocytic leukaemia by interfering with environmental protection and increases response to fludarabine 108
Immune profiling and quantitative analysis decipher the clinical role of immune-checkpoint expression in the tumor immune microenvironment of DLBCL 108
B lymphocytes directly contribute to tissue fibrosis in IgG4-Related Disease 108
Large B-Cell Lymphoma with IRF4 Rearrangement: A Multicentric Italian Study with Focus on Phenotypic and Cytogenetic Features 107
Plasma cells require autophagy for sustainable immunoglobulin production 106
Bone Marrow Histopathology in the Diagnostic Evaluation of Splenic Marginal-zone and Splenic Diffuse Red Pulp Small B-cell Lymphoma: A Reliable Substitute for Spleen Histopathology? 106
MYD88 L265P mutation and interleukin-10 detection in cerebrospinal fluid are highly specific discriminating markers in patients with primary central nervous system lymphoma: results from a prospective study 106
The impact of histopathologic diagnosis on the proper management of testis neoplasms 103
Activity of rituximab in extranodal marginal zone lymphomas (MALT-type). 103
HIF-1α regulates the interaction of chronic lymphocytic leukemia cells with the tumor microenvironment 103
Oncogene-induced senescence in hematopoietic progenitors features myeloid restricted hematopoiesis, chronic inflammation and histiocytosis 103
Lenalidomide enhances CD23.CAR T cell therapy in chronic lymphocytic leukemia 103
Kikuchi-Fujimoto Disease Shows Frequent T-Cell Antigen Loss and MUM1 Expression in Cytotoxic T Cells: a Multi-institutional Italian Study 102
Long-lasting efficacy and safety of lenalidomide maintenance in patients with relapsed diffuse large B-cell lymphoma who are not eligible for or failed autologous transplantation 102
A novel patient-derived tumorgraft model with TRAF1-ALK anaplastic large-cell lymphoma translocation 101
Implications of recent molecular achievements in early diagnosis and precision treatments for primary CNS lymphoma 100
ATR addiction in multiple myeloma: synthetic lethal approaches exploiting established therapies 99
FEASIBILITY AND EFFICACY OF CHLAMYDIA PSITTACI ERADICATION WITH PROLONGED DOXYCYCLINE THERAPY IN LOCALIZED OCULAR ADNEXAE MARGINAL ZONE LYMPHOMA (OAMZL): 7-YEAR RESULTS OF THE IELSG39 MULTICENTER TRIAL 99
Role of next-generation sequencing in acquired amegakaryocytic thrombocytopenic purpura 99
T-N/SCM Pre-Selection Generates CAR T Cell Products Driving Superior Anti-Tumor Responses While Curtailing Severe CRS 99
Clinical Experience in a Large Cohort of Patients with Vitreoretinal Lymphoma in a Single Center 98
Erythroblast apoptosis and microenvironmental iron restriction trigger anemia in the VK*MYC model of multiple myeloma 98
Aberrant methylation in the promoter region of the reduced folate carrier gene is a potential mechanism of resistance to methotrexate in primary central nervous system lymphomas 97
Angiopoietin-2 in Bone Marrow milieu promotes Multiple Myeloma-associated angiogenesis 97
R-CHOP preceded by blood-brain barrier permeabilization with engineered tumor necrosis factor-α in primary CNS lymphoma 97
Gene Expression Profiling Uncovers Molecular Classifiers for the Recognition of Anaplastic Large-Cell Lymphoma Within Peripheral T-Cell Neoplasms 96
Ocular adnexal MALT lymphoma: an intriguing model for antigen-driven lymphomagenesis and microbial-targeted therapy 96
Accelerated progression to AIDS in macaques coinfected with simian immunodeficiency virus and human herpesvirus 6A 94
Atypical presentation of Churg-Strauss syndrome or an undescribed hypereosinophilic disease? 93
Chlamydia infection and lymphoma: Multiple detection methods highlight an association beyond lymphomas of the ocular adnexa 93
International consensus statement on diagnosis, evaluation, and research of Richter transformation: the ERIC recommendations 92
Totale 12.960
Categoria #
all - tutte 236.864
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 236.864


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022301 0 0 0 146 11 12 26 41 10 15 7 33
2022/20232.400 1.054 461 121 10 21 278 117 164 90 27 22 35
2023/20241.220 70 66 97 129 118 223 63 92 32 57 67 206
2024/20256.419 796 102 90 181 169 500 737 513 1.234 1.092 485 520
2025/202621.607 1.425 1.979 2.109 3.201 1.288 548 1.666 1.464 5.516 1.055 630 726
2026/20275.885 951 1.548 1.117 2.269 0 0 0 0 0 0 0 0
Totale 37.998